• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pear Therapeutics, Inc. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series
    From Pear Therapeutics, Inc.
    Via Business Wire
    California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States
    From Pear Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP
    From Pear Therapeutics, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Thursday
      Thursday's session saw 329 companies set new 52-week lows. 
    Via Benzinga
    Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference
    From Pear Therapeutics, Inc.
    Via Business Wire
    Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
    Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
    Via Benzinga
    Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Pear Therapeutics Reports Third Quarter 2022 Results
    From Pear Therapeutics, Inc.
    Via Business Wire
    Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
    Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus... 
    Via Benzinga
    Earnings Scheduled For November 14, 2022
    Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
    Via Benzinga
    Pear Therapeutics to Participate in the BTIG Digital Health Forum
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe
    From Pear Therapeutics, Inc.
    Via Business Wire
    State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022
    From Pear Therapeutics, Inc.
    Via Business Wire
    Avis Budget, Scholastic And Other Big Gainers From Monday
    U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session. 
    Via Benzinga
    Pear Therapeutics Announces Publication of Real-World Data Showing High Rates of Engagement, Retention and Abstinence with reSET®
    From Pear Therapeutics, Inc.
    Via Business Wire
    Netflix, Intuitive Surgical And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
    U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning! 
    Via InvestorPlace
    Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket
    Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. 
    Via Benzinga
    Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium
    From Pear Therapeutics, Inc.
    Via Business Wire
    Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
    From Pear Therapeutics, Inc.
    Via Business Wire
    Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
    Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.